Member Info for Ivyspivey

https://twitter.com/paragoncreative/status/714731497723445249

https://twitter.com/paragoncreative/status/714730694270918657

https://twitter.com/paragoncreative/status/714728228406095873

Not sure Mick but great to see rise here and see what tomorrow brings- is obviously not MTFB based maybe just seller stopped and way oversold

Was not on LSE first thing this morning so not sure why- but happy with deferment especially with prices and MaCAleer family happy to hold.

Extension of CPNs to December 2017. Not recorded on LSE site but see general RNS announcements

Sorry " underlings" are MTFB or KMK

Jackdaw-H77 is referring to MTFB this morning with news of 1st patient in for phase 3. His definitions- mothership is AMP and u feelings are either MTFB or KMK

https://twitter.com/paragoncreative/status/703162375919128576

Hi lospeculatore- yes I am on their e mail list but did not get it so missed it. I understand a little if the history of TYR and TYRU but wish they only had 1 ticker- but think done if the LTH benefited considerably from the transfer. I have worked with some of the BOD in the last and they are decent folk but may drop them a line re.annoncing stuff on TYRU.

Bruno Jactel, chief executive officer at life sciences ... - DirectorsTalk https://www.***************** › bruno-ja... 9 hours ago - Home » Market News » CEO Interviews » Bruno Jactel, chief executive officer at life ... Bruno Jactel, chief executive of TyraTech (LON:TYR), says plans to raise £ 3.6mln are key.

You need to look on TYR site- the TYRUbRNSs always appear there rather than here- historical reasons I suppose but pain in the neck. I missed it as well it was only when I saw Directirs Talk referring to BJ interview I twigged it.

New distributor for Vammoose- new Directirs Talk interview by BJ today

I would stay where you are unless like me you think the action here might start getting a bit hotter over here.Hope so anyway-.

Have my live football/ beer and have lovely wife in Cheshire and loved Thailand and HK but my bar days are long gone. Sounds like you have great life and glad for you. When this comes in we can all. Fulfill our dreams Take care

Hi H77 Are you still in Phillipines- enjoying all the local delights. Good to see a bit of blue here today- tick tick on here and MTFB

Alan Reade was global head of Merial and Bruno Jactel was European Companion Animal Marketing Director and Jonathan Hill(UK Country Manager) was UK Companion Animal Director of Marketing & Technical Services. Merial a JV between Merck/Sanofi( now wholly owned by Sanofi) is about the 3rd largest AH company with particular interests in parasite control( ivermectin and fipronil) in both production and companion animal. For reference I worked at Merial for some time and do know these individuals GLA

While TyraTech's Vamousse line bagged the firm's first revenues, Dr Jactel insists the animal health sector will be its next business focus as it has the biggest sales potential. Initially, the firm will focus on the global livestock external parasite market (valued at around $0.6 billion at retail level) and the livestock dewormer segment ($4.5bn). "Existing products do the job but there are safety issues with many pesticides," he said, also highlighting a buildup of resistance in insects to heavily-used antiparasitics and pesticides. The company also hopes to bring its OutSmart Spray – a non-toxic equine fly spray – to market in the near future. The product will be distributed by SmartPak, the largest on-line retailer of equestrian products in the US. TyraTech is currently working on the product's design and formulation. Nature vs nature-derived Dr Jactel was keen to point out to Animal Pharm that the company's products are not natural per se but 'nature-derived'. The firm has a patented cell-based technology platform that allows for the screening of new active ingredients and serves as the basis for its plant-based formulations. However, the 'nature' label or associations with organic products can be hard to shake. "At the beginning, it was very hard to explain – no-one believed we had products that were from nature that worked," Dr Jactel explained. "But the head lice product was proof we could do it." "Farmers are agnostics. They want to see a product work, that it is safe for the animals, the people and the food chain, know how much it costs and how many times they need to use it."

Even though the insecticides and antiparasitics space is the most competitive area of the animal health industry, North Carolina-based firm TyraTech believes it can carve out a significant market share. Animal Pharm Editor Joseph Harvey met the company's chief executive Dr Bruno Jactel to get the lowdown on the growing demand for non-toxic insecticides. While TyraTech previously focused on the human health market since its inception in 2004, the company is now starting to enter the animal health sector. Last month, the firm signed an agreement with leading US animal health distribution firm MWI Animal Health for its nature-derived PureScience insecticides range in the US. The PureScience product line is designed to provide non-toxic, highly effective and safe insect control in livestock and food production animals. It is effective and fast-acting against all life stages of insects. Crucially, the products kill insect eggs and do not require repeat usage due to their mode of action, thus saving farm labor costs. Dr Bruno Jactel told Animal Pharm it took 10 years for TyraTech to develop its technology and prove its efficacy. However, the company achieved a landmark in 2014 when it launched pesticide-free head lice solutions for children in the US and the UK. The Vamousse range has gained good sales traction via marketing deals with major retailers such as Walmart, CVS and Walgreens in the US, and Boots, Tesco and Sainsbury's in the UK. "We hope this success will translate to other markets," explained Dr Jactel. "We have demonstrated the technology works and we think this will be a growth platform, specifically for food animals." Dr Jactel said TyraTech's portfolio will be the "next frontier" of insecticides for food animals. He said the PureScience range is being developed to meet unmet insecticide needs – such as northern fowl mites and red mite control in chickens – as well as to capitalize on a consumer trend to environmentally-friendly animal treatments. The Morrisville-headquartered firm has made its first PureScience sales in the US via the MWI partnership. Dr Jactel said TyraTech is aiming to secure similar distribution deals in Europe, Asia and Latin America. To support its expansion into animal health, TyraTech secured around £3.2 million ($4.6 million) funding in November 2015. Change of tactics When he joined the company in 2013 from Merial, the TyraTech board made the decision to transform TyraTech from a company which was looking to out-license its products into a fully-integrated entity. "We wanted to focus more on customer needs with our own production, testing and regulatory team," he explained. "There is more value in having your business closer to the customers. It is a way to validate our technology and generate margin, which helps us invest in R&D and helps us innovate." While TyraTech's Vamousse line bagged the firm's

https://twitter.com/paragoncreative/status/699533332737081344